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Abstract 
There are no outcomes-based commissioning structures in child health. This needs to 
change. Preschool wheeze is a very common condition. Many families present at emergency 
departments with their wheezy children and stay briefly. This highlights that this group of 
children may be lacking a more personalised approach. There are no user-friendly patient 
reported outcome measures in preschool wheeze. This needs to change. Research in this 
area is therefore highly anticipated. 
Introduction 
The involvement of patients in both the design and the conduct of research has been 
increasingly promoted by research bodies and policy makers. All members of the public can 
offer their expertise as users of the healthcare system but especially patients who are living 
with a long-term medical condition. Patients are now involved in both the design of 
healthcare interventions and relevant research but also in giving feedback on healthcare 
services provision and in reviewing research proposals and interviewing healthcare research 
staff (1). It is also important to note that many journals will now routinely reject submitted 
studies where patients have not been involved from the very beginning in the design of the 
study. 
The success of research design and implementation can only be assessed by measurable 
outcomes. Traditionally, outcomes of research interventions are defined by the research 
team. In paediatric respiratory conditions outcomes related to number of hospital 
attendances, use of acute medication and lung function measurement have been used to 
monitor response to interventions including pharmacological treatment, but this is 
changing. Understanding what matters to patients has started being considered as equally 
important conventional outcome(s). By understanding which the important outcomes are 
for our patients, we will be in a better position to design meaningful interventions including 
behaviour modifications that are responsible for increasing numbers of avoidable 
emergency department admissions and poor treatment compliance in the UK. 
What is a patient reported outcome measure (PROM)? 
These are tools measuring outcomes that matter to patients, more specifically reflecting 
patients’ or caregivers’ perspective on the impact of the condition on their lives and how 
illness is experienced (for example, ‘can I now climb my stairs?’, rather than ‘has my 
spirometry improved?’). These tools aim to capture the patient’s perspective, so patient 
involvement is required in the development of PROMs. When it comes to the subjective 
experience of their condition, patients and/or their carers can be considered as “experts” and 
they can bring value in conversations/consultations and in defining the importance of  
commonly used outcomes, such as length of hospital stay. As opposed to Quality of Life 
Questionnaires, PROMs are brief tools designed to assess level of health and/or disability as 
perceived by patients/caregivers apart from health-related quality of life only.  In 2009, it 
was suggested that value in healthcare should be assessed by reintroducing point of care 
use of PROMs (4). These are now being used to track outcomes of surgical operations and in 
the USA, PROMs and clinical data are driving improvements in results for children with 
inflammatory bowel disease (5, 6). In the NHS, PROMs have been successfully used to inform 
quality of care for patients undergoing hip replacement surgery, by highlighting the variation 
in cost between different hospitals and by suggesting new measures of assessment of 
efficacy which are of real importance to the patient (7). Physicians are often reluctant to use 
PROMs routinely because of the time they take to use, and a lack of confidence in their 
value. By contrast, many patients welcome PROMs and believe that they need to be used 
routinely in their management (8). There are examples of validated PROMs in Box 1. 
 
How is a PROM developed? 
The first step is the definition of the conceptual and measurement model. The conceptual 
model provides a structured representation of the items (constructs) that will be included in 
the PROM. This conceptual model is usually based on literature review and provides the 
framework of reference. The subsequent measurement model is the result of qualitative 
research with patients and families and aims to map the individual items in the PROM to the 
construct (9). This is an important stage when some of the constructs will not be mapped to 
items if patients/carers do not consider these as important to be included in the PROM tool. 
The steps of the design of a PROM tool are depicted in Figure 1. 
 
Why do we need PROMs for preschool wheeze? 
Recurrent wheeze in preschool children is common. In the UK the highest number of hospital 
admissions with wheeze was in children less than 5 years old (10, 11). The majority of 
preschool children with wheeze suffer from recurrent commonly viral induced attacks, and 
although most remit over time (12), the associated morbidity and hospitalizations throw a 
heavy burden on both the healthcare systems and the families. However, there is often a 
mismatch between wheeze severity and parental response, in particular whether hospital 
management is sought.  Several studies show that nearly a third of children who present to 
emergency departments with a wheeze attack are discharged within four hours (13-15). This 
short avoidable stay indicates that a significant number of preschool wheezers need not have 
sought clinical review at a secondary care setting. These differences will only be understood 
by studying the family perspective. A PROM could be used in the routine management of 
preschool children with recurrent wheeze, to direct discussions around important aspects of 
care. It could also be used as a marker of quality of care to assess performance in primary care 
and in different hospital trusts.  
Are there suitable PROMs in children with recurrent wheeze? 
For preschool children, disease control is assessed by the Test for Respiratory and Asthma 
control (16). The Paediatric Asthma Quality of life questionnaire is another tool used in 
younger children (more than 2 years old). There is also a version that is designed to be 
answered by parents (17, 18). There are two other instruments attempting to assess the 
severity of preschool wheeze attacks and the main parental feelings during the episode (19, 
20). Although these instruments demonstrate how families feel during acute attacks, they do 
not capture the changes in quality of their life over time and are not co-designed with families, 
unlike PROMs. Indeed, we recently published a spotlight which showed that there are no 
PROMs currently used for preschool children with wheeze in the UK, US, Argentina, Greece, 
Italy, Australia, Singapore and India (21). In summary, we have no PROMs for preschool 
wheeze, and, until such exist, we are unlikely to impact hospital attendances or assess new 
interventions in an appropriate manner. 
Conclusion 
Placing the individual at the centre of healthcare is the whole basis for modern medicine, and 
assessing whether this has been achieved throughout the whole cycle of care is very 
important. PROMs can be used to measure the success of treatment and quality of care in 
terms of which are important to patients. Further benefits include informing commissioning 
and use as endpoints in clinical trials. Clinicians should be assisted to use PROMs meaningfully 
as part of a management toolkit. In practice, this means they must be succinct. We do not 
have user-friendly PROMs for preschool wheeze. This omission needs to be rectified, and 
furthermore, suitable PROMs need to be developed for other paediatric diseases which 
currently lack them. Otherwise, the voices of parents and children will not be heard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Box 1. Examples of Patient Reported Outcome Measures (PROMs) and their use 
PROM as a clinical monitoring tool 
PREOM-BMP (2), a 11-item questionnaire measuring the impact of bowel management in children 
and families’ quality of life  
PROM used as an outcome measurement tool in research 
Pedi-IKDC (3), a 15-item instrument assessing health-related quality of life in children with knee 
ligament injury 
PROM used as a quality of care indicator 
EQ-5D (5), a 5-item questionnaire that assesses mobility, self-care, pain, usual activities, and 
psychological status and has been used in the NHS as an outcome measure for patients undergoing 
hip replacement operation 
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Figure 1. figure describing the development, validation and adaptation of PROMs 
 
 
